KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Assets (2016 - 2026)

Medtronic (MDT) has disclosed Assets for 13 consecutive years, with $91.5 billion as the latest value for Q1 2026.

  • Quarterly Assets rose 1.68% to $91.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $91.5 billion through Jan 2026, up 1.68% year-over-year, with the annual reading at $91.7 billion for FY2025, 1.89% up from the prior year.
  • Assets hit $91.5 billion in Q1 2026 for Medtronic, roughly flat from $91.3 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $94.1 billion in Q1 2023 to a low of $89.7 billion in Q3 2024.
  • Historically, Assets has averaged $91.1 billion across 5 years, with a median of $90.9 billion in 2023.
  • Biggest five-year swings in Assets: fell 5.62% in 2022 and later rose 2.54% in 2023.
  • Year by year, Assets stood at $93.2 billion in 2022, then fell by 3.38% to $90.1 billion in 2023, then decreased by 0.05% to $90.0 billion in 2024, then grew by 1.45% to $91.3 billion in 2025, then grew by 0.15% to $91.5 billion in 2026.
  • Business Quant data shows Assets for MDT at $91.5 billion in Q1 2026, $91.3 billion in Q4 2025, and $91.0 billion in Q3 2025.